SCHEMBL6432224

SCHEMBL6432224

COCCOc1cc2nccc(Nc3ccc(Cl)cc3F)c2cc1C#N

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 10/20 0.75
KDR P35968 9/20 0.75
FGFR1 P11362 8/20 0.75
EGFR P00533 4/20 0.55
FLT4 P35916 4/20 0.55
SRC P12931 8/20 0.55
ERBB2 P04626 1/20 0.55
GAK O14976 1/20 0.46
EPHB2 P29323 1/20 0.45
NR4A2 P43354 1/20 0.44
FGFR2 P21802 1/20 0.43
FGFR4 P22455 1/20 0.43
FGFR3 P22607 1/20 0.43
ABL1 P00519 1/20 0.43
BCR P11274 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6432200 0.99 FLT1 (0.74) FLT1KDRFGFR1EGFRFLT4
SCHEMBL6431198 0.86 FLT1 (1.00) FLT1KDRFGFR1EGFRFLT4
Hydrochloric Acid SCHEMBL6431524 0.85 FLT1 (0.98) FLT1KDRFGFR1EGFRFLT4
Hydrochloric Acid SCHEMBL6431009 0.83 FLT1 (0.52) FLT1KDRFGFR1EGFRFLT4
SCHEMBL6431742 0.83 FLT1 (0.61) FLT1KDRFGFR1EGFRFLT4
Hydrochloric Acid SCHEMBL6431020 0.82 FLT1 (0.61) FLT1KDRFGFR1EGFRFLT4
SCHEMBL6431782 0.82 SRC (0.60) FLT1KDRFGFR1EGFRFLT4
SCHEMBL6432228 0.81 FLT1 (0.61) FLT1KDRFGFR1EGFRFLT4
SCHEMBL6430810 0.79 FGFR1 (0.51) FLT1KDRFGFR1EGFRSRC
Hydrochloric Acid SCHEMBL6434964 0.78 FLT1 (0.82) FLT1KDRFGFR1EGFRFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929526-B1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ASTRAZENECA AB (SE) 2005-07-27 EP claimed
US-6809097-B1 ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY ZENECA LIMITED (GB) 2004-10-26 US claimed
EP-0929526-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1999-07-21 EP claimed
WO-1998013350-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1998-04-02 WO claimed
EP-0929526-B1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ASTRAZENECA AB (SE) 2005-07-27 EP disclosed
US-6809097-B1 ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY ZENECA LIMITED (GB) 2004-10-26 US disclosed
EP-0929526-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1999-07-21 EP disclosed
WO-1998013350-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1998-04-02 WO disclosed